Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
May the Force of Giving Be with You to Create a New Hope for America
-
Blink Charging to Host First Quarter Conference Call on Monday, May 11, 2026
-
CHUCK E. CHEESE ANNOUNCES LARGEST SUMMER HIRING PUSH AND NEWSWEEK RECOGNITION
-
Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50
-
4DMT to Participate in Upcoming Investor Conferences
-
Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
-
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
-
CrownTV Rolls Out Samsung 4K Displays Across Janie and Jack Stores in the US and London
-
Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1
-
Danske Bank A/S – major shareholder announcement from BlackRock, Inc.
-
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
-
News Release in accordance with Canadian National Instrument 62-103
-
ASML reports transactions under its current share buyback program
-
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
-
Navitas Semiconductor Appoints Davin Lee as Independent Director to its Board
-
Terra Innovatum Expands U.S. Presence with Pittsburgh, Pa. Headquarters and Leadership Appointments to Advance SOLO™ Licensing Readiness and FOAK Deployment
-
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
-
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
-
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
-
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal
-
LOBO Claw AI Agent Completes New Round of Upgrades with DeepSeek V4 Model Integration
-
Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Me
-
Propella Group and TISTR Sign MOU to Fast-Track Commercialization of Thailand's Deep Tech IP
-
Propella Group and TISTR Sign MOU to Fast-Track Commercialization of Thailand's Deep Tech IP
-
Bitget lists Billions Network (BILL) for Spot Trading
-
Athene Expands Registered Index-Linked Annuity (RILA) Lineup with Launch of Athene Amplify® 3.0
-
Panoro Announces Brokered LIFE Offering for Gross Proceeds of up to $20 Million
-
Diana Shipping Inc. Launches Tender Offer to Acquire All Outstanding Shares of Genco Shipping & Trading for $23.50 Per Share in Cash
-
Diana Shipping Inc. Launches Tender Offer to Acquire All Outstanding Shares of Genco Shipping & Trading for $23.50 Per Share in Cash
-
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
-
Dynacor Group Receives TSX Approval To Renew Normal Course Issuer Bid
-
DEEP SEA MINERALS CORP. PARTICIPATES IN EXIM BANK’S 2026 ANNUAL CONFERENCE IN WASHINGTON, DC
-
Entente Education Canada honours Dr. Roger Wong with Award for Eminent Contribution to Older Adults in Canada
-
L.B. Foster Company Announces Strong Sales Growth and Profitability Expansion in 2026 First Quarter; Reaffirms Full Year 2026 Financial Guidance
-
Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential
-
EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched
-
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
-
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
-
Fervo Energy Announces Launch of its Initial Public Offering
-
FG Nexus Announces Formation of Special Committee to Evaluate Strategic Alternatives including a Potential Business Combination to Build a Leading Platform in Affordable Housing
-
Hubbell to Acquire NSI Industries
-
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
-
Discovery Announces Details of First Quarter 2026 Results Conference Call and Webcast
-
Tyson Foods Second Quarter 2026 Financial Results Available on the Company’s Investor Relations Website
-
Rekor Systems Secures $16.8 Million Contract with Oklahoma District Attorneys Council as Technology Partner for Statewide Uninsured Vehicle Enforcement Program
-
K Wave Media Secures $485M to Launch AI Infrastructure Platform and Eliminates $48M in Debt
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Hypercharge Grows Total Charging Ports by over 45% Through Acquisition of Eddie from AXSO
-
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
-
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
